Home Company Activities Reports Events Contact
Back to All Reports U.S. Economic Impact of Advanced Biofuels Production: Perspectives to 2030
Summary

According to experts from the World Health Organization, the risk of a deadly global influenza pandemic is now greater than at any time in the past several decades. The economic and business consequences of such an event are difficult to predict, especially since it has been more than 35 years since the last, relatively mild, pandemic occurred. Nonetheless, experience with the SARS epidemic indicates that in the early stages of a pandemic, economic shock waves would move around the world much more quickly than the actual spread of the disease, causing severe disruptions to international travel and trade and downward shocks in financial markets.
Preparing for the business and economic challenges that could emerge from the current avian flu crisis in Asia will require supple and sophisticated strategies based on assessments of possible future events that span a wide spectrum of possibilities. In this report, we:

  • Assess the current situation in Asia, explore possible future scenarios, and identify signposts to watch
  • Consider economic and business implications of a global influenza pandemic, taking into consideration lessons learned from SARS, the role of information, and Bio Era’s quantitative assessments of different countries’ exposure to economic disruption from a pandemic
  • Profile areas of opportunity for companies to provide solutions that might reduce the risks of pandemic emergence, or to help mitigate its impacts.

The attention now being paid by the business and financial community to the risks posed by emerging infectious diseases is part of a broader effort to come to terms with the new economics of biosecurity—an interconnected set of biological issues and economic forces that are affecting the global economy in increasingly significant ways. A new focus on these issues is driving stakeholders to develop business strategies that consider the underlying forces and realities of the emerging bioeconomy. These forces include evolutionary processes, such as those at work in disease emergence, as well as the impact of human activities and rapidly advancing biological technology.